Description

Ibrance is a medication used primarily in the treatment of hormone receptor-positive breast cancer. It works by inhibiting specific proteins that promote cancer cell growth, thereby slowing down the progression of the disease.

Interpreter Notes

Interpreters should be aware that Ibrance may be referred to by its generic name, palbociclib, in some contexts. It's important to maintain a formal register and avoid colloquial terms. Ensure clarity in discussions about cancer treatment, as this term may be used frequently in oncology settings.

Example Sentences

EN: The oncologist prescribed Ibrance as part of the treatment plan for the patient's breast cancer.

ES: El oncólogo recetó Ibrance como parte del plan de tratamiento para el cáncer de mama de la paciente.

Common Interpreter Mistakes

Confusing Ibrance with other cancer medications; mispronouncing Ibrance as if it were a common Spanish word; using informal terms instead of the clinical term.